Description
Indication & Scope
QuXinKeZhi® Metoprolol Tartrate Tablets provides treatment of hypertension, stable angina pectoris, various types of arrhythmia, acute and old myocardial infarction, and chronic heart failure.
- Mechanism: A selective beta1-adrenergic receptor blocker that competitively blocks cardiac beta1 receptors, reduces heart rate, myocardial contractility and myocardial oxygen consumption, inhibits abnormal cardiac conduction, and lowers peripheral blood pressure.
- Drug class: Cardioselective beta-adrenergic receptor antagonist.
- Clinical use: Routinely used in cardiovascular department for long-term control of hypertension, symptomatic relief of angina, correction of arrhythmia, secondary prevention of myocardial infarction, and stable heart failure adjuvant treatment.
| Generic Name | Metoprolol Tartrate Tablets |
| Brand Name | QuXinKeZhi®; Betaloc® |
| Ingredient | Metoprolol Tartrate |
| Dosage Form | Tablets |
| Package | QuXinKeZhi:
25mg*30 tablets/box; 25mg*10 tablets/box; 25mg*16 tablets/box; 25mg*20 tablets/box; 25mg*24 tablets/box; 25mg*36 tablets/box; 25mg*40 tablets/box; 25mg*48 tablets/box Betaloc: 25mg*20 tablets*1 blister/box; 25mg*20 tablets*3 blister/box; 25mg*20 tablets*2 blister/box |
| Conditions Treated | Hypertension, angina pectoris, cardiac arrhythmia, myocardial infarction, chronic heart failure |
| Taboos | Contraindicated in patients with severe bradycardia, atrioventricular block, cardiogenic shock, severe heart failure, hypersensitivity to metoprolol tartrate, and untreated pheochromocytoma |
| Place of origin | China |
| Prescription type | Prescription‑only |
| Storage Conditions | Store sealed at room temperature, keep dry and ventilated, avoid direct sunlight and high temperature and humid environment |
| Manufacturer | Zhuhai Tongyuan Pharmaceutical Co., Ltd.; AstraZeneca Pharmaceutical, Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20057288; H32025391 |
| Approval Date | Feb 13, 2025; Jan 22, 2025 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: Individualized dosage based on disease type; initial 25-50 mg twice daily for hypertension and angina, adjusted according to blood pressure and heart rate response.
Time: Administered twice daily at regular intervals, with or after meals.
Instructions for use: Take orally with warm water, swallow whole without crushing or chewing; do not stop medication abruptly to avoid rebound cardiovascular events.
Interaction: Combined use with other beta-blockers enhances inhibitory effect on heart rate; combined use with antiarrhythmic drugs increases bradycardia risk; combined use with hypoglycemic agents masks hypoglycemia tachycardia symptoms.
Side effects: Common fatigue, dizziness, slow heart rate and mild gastrointestinal discomfort; rare hypotension, sleep disturbance, numbness of extremities and allergic rash.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What cardiovascular diseases can Metoprolol Tartrate Tablets treat?
The tablets are applicable for hypertension, angina pectoris, arrhythmia, myocardial infarction and chronic heart failure.
What administration taboo exists for Metoprolol Tartrate Tablets?
Abrupt discontinuation of the drug is prohibited to prevent rebound cardiovascular symptoms.
What population cannot use Metoprolol Tartrate Tablets?
Patients with severe bradycardia, atrioventricular block and cardiogenic shock are contraindicated.
What common adverse reactions may occur during medication of Metoprolol Tartrate Tablets?
Mild fatigue, dizziness, slow heart rate and slight gastrointestinal discomfort may occur routinely.
QuXinKeZhi® | Metoprolol Tartrate Tablets | Cardiovascular Diseases | DengYueRX
INN: Metoprolol Tartrate Tablets
Indications: Cardiovascular Diseases
Dosage Form: Tablets
Strength: 25mg/tablet
Price range: $0.55 through $4.61
